Relx (RELX) Equity Average (2017 - 2025)
On a quarterly basis, Equity Average fell 12.83% to $3.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 billion, a 12.83% decrease, with the full-year FY2025 number at $3.8 billion, down 12.83% from a year prior.
Relx (RELX) has 4 years of Equity Average data on record, last reported at $3.8 billion in Q4 2025.
- Equity Average reached $3.8 billion in Q4 2025 per RELX's latest filing, down from $4.4 billion in the prior quarter.
- Over the last five years, Equity Average for RELX hit a ceiling of $4.4 billion in Q4 2024 and a floor of $3.8 billion in Q4 2025.
- A 3-year average of $4.2 billion and a median of $4.3 billion in 2023 define the central range for Equity Average.
- Peak YoY movement for Equity Average: rose 0.75% in 2024, then fell 12.83% in 2025.
- Tracing RELX's Equity Average over 3 years: stood at $4.3 billion in 2023, then grew by 0.75% to $4.4 billion in 2024, then dropped by 12.83% to $3.8 billion in 2025.
- Business Quant data shows Equity Average for RELX at $3.8 billion in Q4 2025, $4.4 billion in Q4 2024, and $4.3 billion in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - | 3.81 Bn |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - | - |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn | 4.62 Bn |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn | 4.89 Bn |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn | 1.30 Bn |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn | 23.69 Bn |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn | 5.60 Bn |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn | 3.24 Bn |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn | 4.68 Bn |
| 10 | Dolby Laboratories | 5.15 Bn | 4.56 Bn | 350.90 Mn | 2.61 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.81 Bn |
| Dec 31, 2024 | 4.37 Bn |
| Dec 31, 2023 | 4.34 Bn |
| Dec 31, 2017 | 2.97 Bn |